Predictors of disease activity during pregnancy in women with inflammatory bowel disease—a Danish cohort study
Alimentary Pharmacology & Therapeutics · 2023-02 · 57 (3) · 335-344
DOI: 10.1111/apt.17348 ↗At a glance
Kohortenstudie in Alimentary Pharmacology & Therapeutics, published online on 2022-12-14. Written by Thea Vestergaard and 6 co-authors. Institution: Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark. Major MEDLINE topics: Inflammatory Bowel Diseases, Pregnancy Complications. Cited 40 times so far (Crossref); 33 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Aarhus Universitet, Gigtforeningen.
Abstract (original language)
Background and Aims Inflammatory bowel disease (IBD) activity during pregnancy is associated with adverse pregnancy outcomes. We aimed to identify key clinical characteristics that predict disease activity during pregnancy.
Methods
Between January 2008 through 2021, we identified all singleton pregnancies among women with IBD recorded in patient and birth registries at a tertiary IBD centre in Denmark. Maternal and infant data were retrieved from medical records. Demographics, Physicians Global Assessment (PGA) of disease activity 6 months prior to pregnancy and in all three trimesters of pregnancy and pregnancy outcomes were recorded.
Results
In 609 pregnancies, we observed 603 (99.0%) live births. Disease activity in one or more trimesters was seen in 283 women (46.5%). UC phenotype was associated with an increase in risk of disease activity (adjusted OR = 2.6 [1.8–3.9]; p < 0.001). Disease activity within 6 months prior to conceiving (169 women [27.7%]) was associated with an increased risk of continuous disease activity during pregnancy (adjusted OR of 5.3 [3.5–8.2]; p < 0.001). Disease activity during a previous pregnancy was associated with an increased risk of flares in subsequent pregnancies (adjusted OR of 3.2 [1.5–6.6]; p = 0.002). Sustained clinical remission throughout pregnancy was associated with an increased probability of normal birth term, birthweight and low risk of fetal growth restriction (FGR) and stillbirth.
Conclusion
Predictors for disease activity include disease activity in a previous pregnancy and/or prior to conception, as well as UC phenotype. Reassuringly, women with IBD in remission are not at increased risk of adverse pregnancy outcomes.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.
- Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
- Department of Clinical Medicine, Center for Molecular Prediction of Inflammatory Bowel Disease, Aalborg University, Copenhagen, Denmark.
- Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark.
- Department of Obstetrics and Gynaecology, Aarhus University Hospital, Aarhus, Denmark.
- Center for Crohn's and Colitis, Brigham and Women's Hospital, Harvard Medical School, Massachusetts, Boston, USA.
ORCID profiles: Thea Vestergaard, Mette Julsgaard
Funding
- Aarhus Universitet
- Gigtforeningen
Cite
APA
Vestergaard, T., Julsgaard, M., Røsok, J. F., Vestergaard, S. V., Helmig, R. B., Friedman, S., & Kelsen, J. (2023). Predictors of disease activity during pregnancy in women with inflammatory bowel disease—a Danish cohort study. Alimentary Pharmacology & Therapeutics, 57(3), 335-344. https://doi.org/10.1111/apt.17348
Vancouver
Vestergaard T, Julsgaard M, Røsok JF, Vestergaard SV, Helmig RB, Friedman S, et al. Predictors of disease activity during pregnancy in women with inflammatory bowel disease—a Danish cohort study. Alimentary Pharmacology & Therapeutics. 2023;57(3):335-344. doi:10.1111/apt.17348
BibTeX
@article{Vestergaard2023,
author = {Vestergaard, Thea and Julsgaard, Mette and Røsok, Julie F and Vestergaard, Søren V and Helmig, Rikke B and Friedman, Sonia and Kelsen, Jens},
title = {Predictors of disease activity during pregnancy in women with inflammatory bowel disease—a Danish cohort study},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2023},
volume = {57},
number = {3},
pages = {335--344},
doi = {10.1111/apt.17348}
}
EUVIMED